SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN

SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN

Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds of Formula I and II wherein R, R1 and R2 for each formula are defined herein. The invention further includes analogs, prodrugs and pharmaceutical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YANG, KEVIN, PATEL, VINOD F, LI, AIWEN, HUANG, QI, RIAHI, BABAK, NOMAK, RANA, YUAN, CHESTER CHENGUANG, VANDERPLAS, SIMON, POTASHMAN, MICHELE, HARMANGE, JEANRISTOPHE, ASKEW, JR
Format: Patent
Sprache:ger
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YANG, KEVIN
PATEL, VINOD F
LI, AIWEN
HUANG, QI
RIAHI, BABAK
NOMAK, RANA
YUAN, CHESTER CHENGUANG
VANDERPLAS, SIMON
POTASHMAN, MICHELE
HARMANGE, JEANRISTOPHE
ASKEW, JR
description Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds of Formula I and II wherein R, R1 and R2 for each formula are defined herein. The invention further includes analogs, prodrugs and pharmaceutically acceptable salts and derivatives of Formulas I and II, as well as pharmaceutical compositions, medicaments and methods thereof for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE440834TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE440834TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE440834TT13</originalsourceid><addsrcrecordid>eNrjZDAPDnUKDvEMCfV0DQpxVXAMivRx9PX0c3EN8gxzBAqE-rkohLkGhbv6uYT6uQcDmW6OHkGufjwMrGmJOcWpvFCam0HRzTXE2UM3tSA_PrW4IDE5NS-1JB5ohImJgYWxSUiIoTExagCvYymb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN</title><source>esp@cenet</source><creator>YANG, KEVIN ; PATEL, VINOD F ; LI, AIWEN ; HUANG, QI ; RIAHI, BABAK ; NOMAK, RANA ; YUAN, CHESTER CHENGUANG ; VANDERPLAS, SIMON ; POTASHMAN, MICHELE ; HARMANGE, JEANRISTOPHE ; ASKEW, JR</creator><creatorcontrib>YANG, KEVIN ; PATEL, VINOD F ; LI, AIWEN ; HUANG, QI ; RIAHI, BABAK ; NOMAK, RANA ; YUAN, CHESTER CHENGUANG ; VANDERPLAS, SIMON ; POTASHMAN, MICHELE ; HARMANGE, JEANRISTOPHE ; ASKEW, JR</creatorcontrib><description>Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds of Formula I and II wherein R, R1 and R2 for each formula are defined herein. The invention further includes analogs, prodrugs and pharmaceutically acceptable salts and derivatives of Formulas I and II, as well as pharmaceutical compositions, medicaments and methods thereof for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.</description><language>ger</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090915&amp;DB=EPODOC&amp;CC=AT&amp;NR=E440834T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090915&amp;DB=EPODOC&amp;CC=AT&amp;NR=E440834T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YANG, KEVIN</creatorcontrib><creatorcontrib>PATEL, VINOD F</creatorcontrib><creatorcontrib>LI, AIWEN</creatorcontrib><creatorcontrib>HUANG, QI</creatorcontrib><creatorcontrib>RIAHI, BABAK</creatorcontrib><creatorcontrib>NOMAK, RANA</creatorcontrib><creatorcontrib>YUAN, CHESTER CHENGUANG</creatorcontrib><creatorcontrib>VANDERPLAS, SIMON</creatorcontrib><creatorcontrib>POTASHMAN, MICHELE</creatorcontrib><creatorcontrib>HARMANGE, JEANRISTOPHE</creatorcontrib><creatorcontrib>ASKEW, JR</creatorcontrib><title>SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN</title><description>Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds of Formula I and II wherein R, R1 and R2 for each formula are defined herein. The invention further includes analogs, prodrugs and pharmaceutically acceptable salts and derivatives of Formulas I and II, as well as pharmaceutical compositions, medicaments and methods thereof for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPDnUKDvEMCfV0DQpxVXAMivRx9PX0c3EN8gxzBAqE-rkohLkGhbv6uYT6uQcDmW6OHkGufjwMrGmJOcWpvFCam0HRzTXE2UM3tSA_PrW4IDE5NS-1JB5ohImJgYWxSUiIoTExagCvYymb</recordid><startdate>20090915</startdate><enddate>20090915</enddate><creator>YANG, KEVIN</creator><creator>PATEL, VINOD F</creator><creator>LI, AIWEN</creator><creator>HUANG, QI</creator><creator>RIAHI, BABAK</creator><creator>NOMAK, RANA</creator><creator>YUAN, CHESTER CHENGUANG</creator><creator>VANDERPLAS, SIMON</creator><creator>POTASHMAN, MICHELE</creator><creator>HARMANGE, JEANRISTOPHE</creator><creator>ASKEW, JR</creator><scope>EVB</scope></search><sort><creationdate>20090915</creationdate><title>SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN</title><author>YANG, KEVIN ; PATEL, VINOD F ; LI, AIWEN ; HUANG, QI ; RIAHI, BABAK ; NOMAK, RANA ; YUAN, CHESTER CHENGUANG ; VANDERPLAS, SIMON ; POTASHMAN, MICHELE ; HARMANGE, JEANRISTOPHE ; ASKEW, JR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE440834TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>YANG, KEVIN</creatorcontrib><creatorcontrib>PATEL, VINOD F</creatorcontrib><creatorcontrib>LI, AIWEN</creatorcontrib><creatorcontrib>HUANG, QI</creatorcontrib><creatorcontrib>RIAHI, BABAK</creatorcontrib><creatorcontrib>NOMAK, RANA</creatorcontrib><creatorcontrib>YUAN, CHESTER CHENGUANG</creatorcontrib><creatorcontrib>VANDERPLAS, SIMON</creatorcontrib><creatorcontrib>POTASHMAN, MICHELE</creatorcontrib><creatorcontrib>HARMANGE, JEANRISTOPHE</creatorcontrib><creatorcontrib>ASKEW, JR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YANG, KEVIN</au><au>PATEL, VINOD F</au><au>LI, AIWEN</au><au>HUANG, QI</au><au>RIAHI, BABAK</au><au>NOMAK, RANA</au><au>YUAN, CHESTER CHENGUANG</au><au>VANDERPLAS, SIMON</au><au>POTASHMAN, MICHELE</au><au>HARMANGE, JEANRISTOPHE</au><au>ASKEW, JR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN</title><date>2009-09-15</date><risdate>2009</risdate><abstract>Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds of Formula I and II wherein R, R1 and R2 for each formula are defined herein. The invention further includes analogs, prodrugs and pharmaceutically acceptable salts and derivatives of Formulas I and II, as well as pharmaceutical compositions, medicaments and methods thereof for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE440834TT1
source esp@cenet
title SUBSTITUIERTE ARYLAMINDERIVATE UND VERWENDUNGSVERFAHREN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A10%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YANG,%20KEVIN&rft.date=2009-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE440834TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true